Immunotherapy
Page 1 • 4 itemsUnlock global immunotherapy market insights. NovaPharmaNews delivers critical intelligence for pharma BD, investors & analysts. Stay ahead.
Oncolytics Biotech Pelareorep Shows Durable Responses in RAS-Mutant Colorectal Cancer Trial
Oncolytics Biotech reports sustained clinical benefit with pelareorep immunotherapy in second-line RAS-mutant MSS colorectal cancer patients.
Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins as Strategic Adviser for DCVax Cancer Vaccine Development
Northwest Biotherapeutics names Dr. Annalisa Jenkins as Strategic Adviser to advance DCVax dendritic cell cancer vaccine platform with 25+ years biopharma experience.
Adagene's Muzastotug Shows 66.7% Response Rate in Triple Combination Therapy for Hepatocellular Carcinoma at AACR 2026
Adagene's muzastotug demonstrates superior efficacy in combination therapy for liver cancer, achieving 66.7% response rate versus 32.5% control in Phase 1b/2 trial.
GlycoNex GNX1021 Gets PMDA Approval for First-in-Human Phase 1 Trial in Gastrointestinal Cancers
GlycoNex receives PMDA approval to begin first-in-human Phase 1 trial of GNX1021 antibody-drug conjugate for advanced gastrointestinal cancers in Japan.